Skip to content

Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea

Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02515409
Enrollment
40
Registered
2015-08-04
Start date
2015-08-31
Completion date
2017-08-31
Last updated
2015-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Keywords

Obstructive Sleep Apnea Syndrome (OSAS), Heated Humidified High Flow Nasal Cannula (HHHNC), Continues positive airway pressure (CPAP), Children, Non invasive ventilation, Treatment

Brief summary

The purpose of this study is to determine whether heated humidified high flow nasal cannula (HHHFNC) is effective as a treatment of obstructive sleep apnea syndrome (OSAS) compared to continues positive airway pressure (CPAP) treatments in children and to compare their adherence and compliance.

Interventions

DEVICEHHHFNC

After the treatment with CPAP fails, the participants will use HHHFNC as a treatment for OSAS.

DEVICECPAP

CPAP, as a first line treatment in OSAS.

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No

Inclusion criteria

s: * Age: 0-16 years old. * Refered for treatment with non invasive ventilation. * Diagnosed with OSAS and AHI\>=5 There are no

Design outcomes

Primary

MeasureTime frame
Average hours per night and per week using HHHFNC .One year
Average hours per night and per week using CPAP.One year

Secondary

MeasureTime frameDescription
Apnea hypopnea index (AHI)One yearSeverity of sleep apnea using AHI.
Pediatric sleep questionnaire (PSQ) scoreOne yearObstructive sleep-related breathing disorders using PSQ score

Contacts

Primary ContactKeren Armoni-Domany, Dr.
domany@gmail.com+972-3-6974614

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026